SCHEMBL3979117

SCHEMBL3979117

Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cc(C)c1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 9/20 0.46
NR1H3 Q13133 9/20 0.46
FFAR1 O14842 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
PTPN1 P18031 1/20 0.42
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
PGR P06401 2/20 0.41
MLYCD O95822 1/20 0.41
LIPE Q05469 1/20 0.41
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TBXA2R P21731 1/20 0.40
PTGER1 P34995 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3980975 0.85 NR1H2 (0.45) NR1H2NR1H3MLYCD
SCHEMBL3980539 0.82 FFAR4 (0.52) NR1H2NR1H3FFAR4MAPTMAPK1
SCHEMBL11304784 0.80 NR1H3 (0.47) NR1H2NR1H3PTPN1MLYCD
SCHEMBL11313898 0.80 SCN8A (0.58)
SCHEMBL13169327 0.79 L3MBTL1 (0.46) FFAR4PTPN1LMNAHPGDLIPE
SCHEMBL14112773 0.79 MAPT (0.46) FFAR4PTPN1LMNAHPGDLIPE
SCHEMBL11315931 0.79 KMT2A (0.66) LMNAHPGDMLYCDMAPTL3MBTL1
SCHEMBL7535983 0.79 LMNA (0.53) FFAR4PTPN1LMNAHPGDLIPE
SCHEMBL11307156 0.78 MLYCD (0.50) NR1H2NR1H3PTPN1LMNAMLYCD
SCHEMBL8555303 0.77 KDM1A (0.49) PTPN1LMNAHPGDLIPEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101031540-B Hexafluoroisopropanol substituted ether derivatives HOFFMANN LA ROCHE 2010-05-26 CN claimed
US-7473705-B2 Hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. (US) 2009-01-06 US claimed
EP-1802566-B1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-11-26 EP claimed
CN-101031540-A Hexafluoroisopropanol substituted ether derivatives HOFFMANN LA ROCHE (CH) 2007-09-05 CN claimed
EP-1802566-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-07-04 EP claimed
WO-2006037480-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-04-13 WO claimed
US-20060074115-A1 Novel hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. 2006-04-06 US claimed
CN-101031540-B Hexafluoroisopropanol substituted ether derivatives HOFFMANN LA ROCHE 2010-05-26 CN disclosed
US-7473705-B2 Hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. (US) 2009-01-06 US disclosed
EP-1802566-B1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-11-26 EP disclosed
CN-101031540-A Hexafluoroisopropanol substituted ether derivatives HOFFMANN LA ROCHE (CH) 2007-09-05 CN disclosed
EP-1802566-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-07-04 EP disclosed
WO-2006037480-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-04-13 WO disclosed
US-20060074115-A1 Novel hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074115-A1 Novel hexafluoroisopropanol substituted ether derivatives NR1H3, NR1H2, NR1I2 NR1H2 2/4885NR1H3 1/4885FFAR1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.